Correlations of MicroRNA-487a-3p and A Kinase-Interacting Protein 1 mRNA Levels in Endometrial Cancer Tissue With

Dan-Dan Zhao1, Su-E Zhang1, Li-Ye Miao1

  • 1Department of Obstetrics,The Fourth Hospital of Shijiazhuang,Shijiazhuang 050032,China.

Insights

Endometrial cancer (EC) tissue exhibits lower microRNA-487a-3p (miR-487a-3p) and higher A kinase-interacting protein 1 (AKIP1) mRNA levels, both correlating with poorer prognosis. These biomarkers can predict EC patient survival within five years post-surgery.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Research

Background:

  • Endometrial cancer (EC) prognosis is influenced by molecular factors.
  • MicroRNAs (miRNAs) and messenger RNAs (mRNAs) play critical roles in cancer development and progression.

Purpose of the Study:

  • To investigate the expression of microRNA-487a-3p (miR-487a-3p) and A kinase-interacting protein 1 (AKIP1) mRNA in EC tissue.
  • To determine the relationship between these molecules and patient survival within five years post-surgery.

Main Methods:

  • Collected EC and adjacent normal tissues from 130 EC patients.
  • Quantified miR-487a-3p and AKIP1 mRNA expression using qRT-PCR.
  • Verified the targeting relationship between miR-487a-3p and AKIP1 using dual luciferase reporter gene assay.
  • Analyzed correlations with clinicopathological parameters and survival outcomes.

Main Results:

  • EC tissue showed significantly lower miR-487a-3p and higher AKIP1 mRNA levels compared to normal tissue.
  • Low miR-487a-3p and high AKIP1 mRNA expression correlated with advanced FIGO stage, lymph node metastasis, and poor tumor differentiation.
  • Both miR-487a-3p and AKIP1 mRNA levels independently predicted 5-year survival, with combined analysis yielding higher predictive accuracy (AUC=0.908).

Conclusions:

  • Reduced miR-487a-3p and elevated AKIP1 mRNA are characteristic of EC tissue.
  • These molecular markers are significantly associated with adverse clinicopathological features and prognosis.
  • miR-487a-3p and AKIP1 mRNA serve as valuable predictive biomarkers for EC patient survival.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K